Rayman R B
Aviat Space Environ Med. 1979 Nov;50(11):1170-2.
Sickle cell trait (SCT) for years has been a controversial disorder within the aerospace medicine community. Some authorities consider SCT to be an entirely benign condition without particular significance, at least to moderate altitudes. Others are in disagreement and consider it a serious enough threat that flying duties should be precluded for all individuals with this disorder. These issues are addressed by reviewing SCT, its relationship to altitude, and its risk to aviation. The author concludes that flying organizations must establish their own policy on flying status for individuals with SCT based upon mission peculiarities and the assessment of risk inherent in that mission.
多年来，镰状细胞性状（SCT）在航空航天医学界一直是一种存在争议的病症。一些权威人士认为SCT完全是一种良性状况，没有特别的重要性，至少在中等海拔高度是这样。另一些人则持不同意见，认为它是一个足够严重的威胁，所有患有这种病症的人都应被禁止执行飞行任务。通过回顾SCT、它与海拔高度的关系以及它对航空的风险来探讨这些问题。作者得出结论，飞行组织必须根据任务特点以及该任务所固有的风险评估，为患有SCT的人员制定自己的飞行状态政策。
